ADC Therapeutics SA reports results for the quarter ended September 30 - Earnings Summary

ADC Therapeutics SA

08/11/2024 21:48

* ADC Therapeutics SA  ADCT.N  reported a quarterly adjusted
loss
of 42 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -58 cents.  The mean expectation of six analysts
for the quarter was for a loss of 39 cents per share. Wall
Street expected results to range from -55 cents to -32 cents per
share.
    * Revenue rose 27.4% to $18.46 million from a year ago;
analysts
expected $18.46 million. 
    * ADC Therapeutics SA's reported EPS for the quarter was a
loss
of 42 cents​.
    * The company reported a quarterly loss of $43.97 million.
    * ADC Therapeutics SA shares had fallen by 7.0% this
quarter and
gained 76.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for ADC Therapeutics
SA is 9.00 
This summary was machine generated from LSEG data November 8 at
09:48 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.39          -0.42          Missed
 Jun. 30 2024      -0.46          -0.38          Beat
 Mar. 31 2024      -0.56          -0.56          Met
 Dec. 31 2023      -0.50          -1.03          Missed